Nitrofurantoin (CKD Contraindication)
Brand names: Macrobid, Macrodantin
Nitrofurantoin is an oral urinary antiseptic for lower urinary tract infection; this entry highlights its restriction in chronic kidney disease, where reduced renal function limits its use.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It is concentrated in the urine, where it is reduced by bacterial enzymes to reactive intermediates that damage ribosomal proteins, DNA and other macromolecules, giving activity confined largely to the urinary tract.
Prescribing in practice
- Nitrofurantoin should be avoided when renal function is significantly impaired because inadequate urinary concentrations make it ineffective while systemic accumulation raises the risk of peripheral neuropathy and pulmonary toxicity; check eGFR before prescribing.
- It is contraindicated in infants in the first months of life and in G6PD deficiency owing to the risk of haemolysis.
- Long-term use carries risks of chronic pulmonary fibrosis and hepatotoxicity, so prolonged courses need review.
Monitoring
Check renal function before prescribing and, with extended use, monitor for pulmonary, hepatic and neurological adverse effects.
Counselling the patient
- Take with food to reduce stomach upset, and expect your urine may turn dark yellow or brown.
- Report new tingling or numbness, breathlessness or persistent cough.
Evidence & guidelines
Long clinical experience and current prescribing references define its efficacy in uncomplicated cystitis and the renal threshold below which it is no longer recommended, with the threshold periodically revised.
Reference: MHRA DSU 2014 (Nitrofurantoin in Renal Impairment); NICE NG109 (UTI — Adults); SPC Macrobid; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Vancomycin Dosing Calculator · Drug Dosing
- Phenytoin Correction for Albumin / Renal Failure · Drug Dosing
- Local Anaesthetic Maximum Dose Calculator · Drug Dosing
- SVT Termination Score and Adenosine Dosing · Arrhythmia
- Ideal & Adjusted Body Weight · Body Composition
- Weight-Based Levothyroxine Dose Calculator · Thyroid
- Hyperkalaemia Management · UK Kidney Association Guidelines 2020; NICE CKD Guidelines
- Rhabdomyolysis · Renal Association 2018; UpToDate 2024
- Hypocalcaemia (Adult) · Society for Endocrinology
- SIADH (Endocrine Perspective) · European Hyponatraemia Guidelines 2014
- Hepatorenal Syndrome · EASL 2018; ICA 2015
- Acute Kidney Injury (AKI) · KDIGO 2012 / NICE AKI 2019